Clinical trial
A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
NCT00076323 is registered in ClinicalTrials.gov with Walter Reed Army Institute of Research (WRAIR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
- Lead sponsor
- Walter Reed Army Institute of Research (WRAIR)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- November 30, 2006
- Enrollment
- 14
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.